Logo image of SLRN

ACELYRIN INC (SLRN) Stock Analyst Ratings

NASDAQ:SLRN - Nasdaq - US00445A1007 - Common Stock - Currency: USD

2.27  +0.04 (+1.79%)

After market: 2.25 -0.02 (-0.88%)

Buy % Consensus

85

ChartMill assigns a Buy % Consensus number of 85% to SLRN. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 8.16. This target is 259.47% above the current price.
SLRN was analyzed by 8 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about SLRN.
In the previous month the buy percentage consensus was at a similar level.
SLRN was analyzed by 8 analysts. More opinions would make the average more meaningful.
SLRN Historical Analyst RatingsSLRN Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -23 -21 -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 2.278.088.168.168.40 - 255.95% 259.47% 259.47% 270.04%
SLRN Current Analyst RatingSLRN Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2025-01-07 Citigroup Maintains Neutral -> Neutral
2025-01-07 HC Wainwright & Co. Maintains Neutral -> Neutral
2024-12-11 Wells Fargo Maintains Overweight -> Overweight
2024-12-11 HC Wainwright & Co. Reiterate Neutral -> Neutral
2024-11-14 HC Wainwright & Co. Maintains Neutral -> Neutral
2024-10-16 Wells Fargo Maintains Overweight -> Overweight
2024-08-19 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2024-08-15 HC Wainwright & Co. Downgrade Buy -> Neutral
2024-08-14 Piper Sandler Maintains Overweight -> Overweight
2024-07-08 Wells Fargo Upgrade Equal-Weight -> Overweight
2024-05-22 HC Wainwright & Co. Maintains Buy -> Buy
2024-05-15 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-09 HC Wainwright & Co. Maintains Buy -> Buy
2024-04-01 HC Wainwright & Co. Reiterate Buy -> Buy
2024-03-21 Wells Fargo Maintains Equal-Weight -> Equal-Weight
2024-03-20 HC Wainwright & Co. Reiterate Buy -> Buy
2024-03-12 HC Wainwright & Co. Reiterate Buy -> Buy
2023-12-13 Wells Fargo Initiate Equal-Weight
2023-12-08 Citigroup Initiate Neutral
2023-11-29 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2023-11-28 Jefferies Maintains Buy -> Buy
2023-11-28 HC Wainwright & Co. Reiterate Buy -> Buy
2023-09-13 Morgan Stanley Downgrade Overweight -> Equal-Weight
2023-09-12 HC Wainwright & Co. Reiterate Buy -> Buy
2023-09-05 Morgan Stanley Maintains Overweight -> Overweight
2023-09-05 HC Wainwright & Co. Initiate Buy
2023-06-21 Morgan Stanley Reiterate Overweight -> Overweight
2023-05-30 TD Cowen Initiate Outperform
2023-05-30 Morgan Stanley Initiate Overweight
2023-05-30 Piper Sandler Initiate Overweight